The impact of external factors on psoriasis

[1] Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017; 31: 205–212. MichalekIM LoringB JohnSM A systematic review of worldwide epidemiology of psoriasis J Eur Acad Dermatol Venereol 2017 31 205 212 10.1111/jdv.1385427573025 Search in Google Scholar

[2] Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003; 4: 771–788. LodénM Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders Am J Clin Dermatol 2003 4 771 788 10.2165/00128071-200304110-0000514572299 Search in Google Scholar

[3] Lebwohl M, Herrmann LG. Impaired skin barrier function in dermatologic disease and repair with moisturization. Cutis. 2005; 76: 7–12. LebwohlM HerrmannLG Impaired skin barrier function in dermatologic disease and repair with moisturization Cutis 2005 76 7 12 Search in Google Scholar

[4] Welz-Kubiak K, Reich A. Znaczenie emolientów w codziennej pielęgnacji skóry. Forum Dermatol. 2016; 2: 20–23. Welz-KubiakK ReichA Znaczenie emolientów w codziennej pielęgnacji skóry Forum Dermatol 2016 2 20 23 Search in Google Scholar

[5] Ng JP, Liew HM, Ang SB. Use of emollients in atopic dermatitis. J Eur Acad Dermatol Venereol. 2015; 29: 854–857. NgJP LiewHM AngSB Use of emollients in atopic dermatitis J Eur Acad Dermatol Venereol 2015 29 854 857 10.1111/jdv.1286425444256 Search in Google Scholar

[6] Sikorska M, Nowicki R, Wilkowska A. Pielęgnacja skóry suchej i wrażliwej. Polish J Allergol. 2015; 2: 158–161. SikorskaM NowickiR WilkowskaA Pielęgnacja skóry suchej i wrażliwej Polish J Allergol 2015 2 158 161 10.1016/j.alergo.2015.11.003 Search in Google Scholar

[7] Fluhr JW, Cavallotti C, Berardesca E. Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol. 2008; 26: 380–386. FluhrJW CavallottiC BerardescaE Emollients, moisturizers, and keratolytic agents in psoriasis Clin Dermatol 2008 26 380 386 10.1016/j.clindermatol.2008.01.01518691519 Search in Google Scholar

[8] Proksch E, Lachapelle JM. The management of dry skin with topical emollients - Recent perspectives. J Dtsch Dermatol Ges. 2005; 3: 768–774. ProkschE LachapelleJM The management of dry skin with topical emollients - Recent perspectives J Dtsch Dermatol Ges 2005 3 768 774 10.1111/j.1610-0387.2005.05068.x16194154 Search in Google Scholar

[9] Silny W, Czarnecka-Operacz M, Gliński W, Samochocki Z, Jenerowicz D. Atopowe zapalenie skóry - Współczesne poglądy na patomechanizm oraz metody postępowania diagnostyczno-leczniczego. Stanowisko grupy specjalistów Polskiego Towarzystwa Dermatologicznego. Post Dermatol Alergol. 2010; 27: 365–383. SilnyW Czarnecka-OperaczM GlińskiW SamochockiZ JenerowiczD Atopowe zapalenie skóry - Współczesne poglądy na patomechanizm oraz metody postępowania diagnostyczno-leczniczego. Stanowisko grupy specjalistów Polskiego Towarzystwa Dermatologicznego Post Dermatol Alergol 2010 27 365 383 Search in Google Scholar

[10] Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: A comprehensive review of the clinical literature. Dermatol Online J. 2013; 19: 20392. PanM HeineckeG BernardoS TsuiC LevittJ Urea: A comprehensive review of the clinical literature Dermatol Online J 2013 19 20392 10.5070/D31911020392 Search in Google Scholar

[11] Grether-Beck S, Felsner I, Brenden H, Kohne Z, Majora M, Marini A, Jaenicke T, Rodriguez-Martin M, Trullas C, Hupe M, et al. Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol. 2012; 132: 1561–1572. Grether-BeckS FelsnerI BrendenH KohneZ MajoraM MariniA JaenickeT Rodriguez-MartinM TrullasC HupeM Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression J Invest Dermatol 2012 132 1561 1572 10.1038/jid.2012.42335296522418868 Search in Google Scholar

[12] Bristow I. Emollients in the care of the diabetic foot. Diabet Foot J. 2013; 16: 63–66. BristowI Emollients in the care of the diabetic foot Diabet Foot J 2013 16 63 66 Search in Google Scholar

[13] Choi MJ, Maibach HI. Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol. 2005; 6: 215–223. ChoiMJ MaibachHI Role of ceramides in barrier function of healthy and diseased skin Am J Clin Dermatol 2005 6 215 223 10.2165/00128071-200506040-0000216060709 Search in Google Scholar

[14] Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol. 1994; 130: 452–456. MottaS MontiM SesanaS MellesiL GhidoniR CaputoR Abnormality of water barrier function in psoriasis. Role of ceramide fractions Arch Dermatol 1994 130 452 456 10.1001/archderm.1994.01690040056007 Search in Google Scholar

[15] Coderch L, López O, de la Maza A, Parra JL. Ceramides and skin function. Am J Clin Dermatol. 2003; 4: 107–129. CoderchL LópezO de la MazaA ParraJL Ceramides and skin function Am J Clin Dermatol 2003 4 107 129 10.2165/00128071-200304020-0000412553851 Search in Google Scholar

[16] Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, Mettang T, Gieler U, Lotti T, Lambert J, Maisel P, et al. European guideline on chronic pruritus. Acta Derm Venereol. 2012; 92: 563–581. WeisshaarE SzepietowskiJC DarsowU MiseryL WallengrenJ MettangT GielerU LottiT LambertJ MaiselP European guideline on chronic pruritus Acta Derm Venereol 2012 92 563 581 10.2340/00015555-140022790094 Search in Google Scholar

[17] Korponyai C, Szél E, Behány Z, Varga E, Mohos G, Dura Á, Dikstein S, Kemény L, Erős G. Effects of locally applied glycerol and xylitol on the hydration, barrier function and morphological parameters of the skin. Acta Derm Venereol. 2017; 97: 182–187. KorponyaiC SzélE BehányZ VargaE MohosG DuraÁ DiksteinS KeményL ErősG Effects of locally applied glycerol and xylitol on the hydration, barrier function and morphological parameters of the skin Acta Derm Venereol 2017 97 182 187 10.2340/00015555-249327349297 Search in Google Scholar

[18] Ungerstedt JS, Blombäck M, Söderström T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol. 2003; 131: 48–52. UngerstedtJS BlombäckM SöderströmT Nicotinamide is a potent inhibitor of proinflammatory cytokines Clin Exp Immunol 2003 131 48 52 10.1046/j.1365-2249.2003.02031.x180859812519385 Search in Google Scholar

[19] Merial-Kieny C, Mengual X, Guerrero D, Sibaud V. Clinical efficacy of Avène hydrotherapy measured in a large cohort of more than 10,000 atopic or psoriatic patients. J Eur Acad Dermatol Venereol. 2011; 25: 30–34. Merial-KienyC MengualX GuerreroD SibaudV Clinical efficacy of Avène hydrotherapy measured in a large cohort of more than 10,000 atopic or psoriatic patients J Eur Acad Dermatol Venereol 2011 25 30 34 10.1111/j.1468-3083.2010.03900.x21175872 Search in Google Scholar

[20] Luger T, Seite S, Humbert P, Krutmann J, Triller R, Dréno B. Recommendations for adjunctive basic skin care in patients with psoriasis. Eur J Dermatol. 2014; 24: 194–200. LugerT SeiteS HumbertP KrutmannJ TrillerR DrénoB Recommendations for adjunctive basic skin care in patients with psoriasis Eur J Dermatol 2014 24 194 200 10.1684/ejd.2014.229424721699 Search in Google Scholar

[21] Szepietowski J, Adamski Z, Chodorowska G, Gliński W, Kaszuba A, Placek W, Rudnicka L, Reich A. Leczenie łuszczycy zwyczajnej - Rekomendacje ekspertów Polskiego Towarzystwa Dermatologicznego. Część I: Łuszczyca łagodna, łuszczyca wieku dziecięcego. Przegl Dermatol. 2012; 99: 83–96. SzepietowskiJ AdamskiZ ChodorowskaG GlińskiW KaszubaA PlacekW RudnickaL ReichA Leczenie łuszczycy zwyczajnej - Rekomendacje ekspertów Polskiego Towarzystwa Dermatologicznego. Część I: Łuszczyca łagodna, łuszczyca wieku dziecięcego Przegl Dermatol 2012 99 83 96 Search in Google Scholar

[22] Draelos ZD. Moisturizing cream ameliorates dryness and desquamation in participants not receiving topical psoriasis treatment. Cutis. 2008; 82: 211–216. DraelosZD Moisturizing cream ameliorates dryness and desquamation in participants not receiving topical psoriasis treatment Cutis 2008 82 211 216 Search in Google Scholar

[23] Wohlrab W. Recovery rate of externally administered glucocorticoids on the skin surface. Dermatol Monatsschr. 1986; 172: 615–619. WohlrabW Recovery rate of externally administered glucocorticoids on the skin surface Dermatol Monatsschr 1986 172 615 619 Search in Google Scholar

[24] Watsky KL, Freije L, Leneveu MC, Wenck HA, Leffell DJ. Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis. 1992; 50: 383–386. WatskyKL FreijeL LeneveuMC WenckHA LeffellDJ Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis Cutis 1992 50 383 386 Search in Google Scholar

[25] Seité S, Khemis A, Rougier A, Ortonne JP. Emollient for maintenance therapy after topical corticotherapy in mild psoriasis. Exp Dermatol. 2009; 18: 1076–1078. SeitéS KhemisA RougierA OrtonneJP Emollient for maintenance therapy after topical corticotherapy in mild psoriasis Exp Dermatol 2009 18 1076 1078 10.1111/j.1600-0625.2009.00903.x19453736 Search in Google Scholar

[26] Lacarrubba F, Musumeci1 ML, Milani M, Micali G. Corticosteroid cream once daily plus an emollient cream in comparison with corticosteroid cream twice daily in plaque psoriasis: An intra-patient, randomized assessor-blinded, ultrasound evaluation study. J Clin Exp Dermatol Res. 2014; 5: 243. LacarrubbaF Musumeci1ML MilaniM MicaliG Corticosteroid cream once daily plus an emollient cream in comparison with corticosteroid cream twice daily in plaque psoriasis: An intra-patient, randomized assessor-blinded, ultrasound evaluation study J Clin Exp Dermatol Res 2014 5 243 10.4172/2155-9554.1000243 Search in Google Scholar

[27] Fry L, Baker BS. Triggering psoriasis: The role of infections and medications. Clin Dermatol. 2007; 25: 606–615. FryL BakerBS Triggering psoriasis: The role of infections and medications Clin Dermatol 2007 25 606 615 10.1016/j.clindermatol.2007.08.01518021899 Search in Google Scholar

[28] Keller JJ, Lin HC. The effects of chronic periodontitis and its treatment on the subsequent risk of psoriasis. Br J Dermatol. 2012; 167: 1338–1344. KellerJJ LinHC The effects of chronic periodontitis and its treatment on the subsequent risk of psoriasis Br J Dermatol 2012 167 1338 1344 10.1111/j.1365-2133.2012.11126.x22755552 Search in Google Scholar

[29] El-Rachkidy RG, Hales JM, Freestone PP, Young HS, Griffiths CE, Camp RD. Increased blood levels of IgG reactive with secreted Streptococcus pyogenes proteins in chronic plaque psoriasis. J Invest Dermatol. 2007; 127: 1337–1342. El-RachkidyRG HalesJM FreestonePP YoungHS GriffithsCE CampRD Increased blood levels of IgG reactive with secreted Streptococcus pyogenes proteins in chronic plaque psoriasis J Invest Dermatol 2007 127 1337 1342 10.1038/sj.jid.570074417344934 Search in Google Scholar

[30] Rantakokko K, Rimpiläinen M, Uksila J, Jansèn C, Luukkainen R, Toivanen P. Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol. 1997; 15: 399–404. RantakokkoK RimpiläinenM UksilaJ JansènC LuukkainenR ToivanenP Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis Clin Exp Rheumatol 1997 15 399 404 Search in Google Scholar

[31] Atefi N, Noorbakhsh S, Darestani SG, Tabatabaei A, Rezaee M. The rise of staphylococcal super antigens in psoriatic patients: A case-control study. Jundishapur J Microbiol., 2014; 7: e9912. AtefiN NoorbakhshS DarestaniSG TabatabaeiA RezaeeM The rise of staphylococcal super antigens in psoriatic patients: A case-control study Jundishapur J Microbiol 2014 7 e9912 10.5812/jjm.9912413864625147719 Search in Google Scholar

[32] De Jesús-Gil C, Ruiz-Romeu E, Ferran M, Chiriac A, Deza G, Hóllo P, Celada A, Pujol RM, Santamaria-Babí LF. CLA⁺ T cell response to microbes in psoriasis. Front Immunol. 2018; 9: 1488. De Jesús-GilC Ruiz-RomeuE FerranM ChiriacA DezaG HólloP CeladaA PujolRM Santamaria-BabíLF CLA⁺ T cell response to microbes in psoriasis Front Immunol 2018 9 1488 10.3389/fimmu.2018.01488603626330013558 Search in Google Scholar

[33] Lewis DJ, Chan WH, Hinojosa T, Hsu S, Feldman SR. Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review. Clin Dermatol. 2019; 37: 160–166. LewisDJ ChanWH HinojosaT HsuS FeldmanSR Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review Clin Dermatol 2019 37 160 166 10.1016/j.clindermatol.2019.01.01130981296 Search in Google Scholar

[34] Thorleifsdottir RH, Eysteinsdóttir JH, Olafsson JH, Sigurdsson MI, Johnston A, Valdimarsson H, Sigurgeirsson B. Throat infections are associated with exacerbation in a substantial proportion of patients with chronic plaque psoriasis. Acta Derm Venereol. 2016; 96: 788–791. ThorleifsdottirRH EysteinsdóttirJH OlafssonJH SigurdssonMI JohnstonA ValdimarssonH SigurgeirssonB Throat infections are associated with exacerbation in a substantial proportion of patients with chronic plaque psoriasis Acta Derm Venereol 2016 96 788 791 10.2340/00015555-2408499512026984718 Search in Google Scholar

[35] Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL, Gudjonsson JE, Johnston A. Psoriasis - as an autoimmune disease caused by molecular mimicry. Trends Immunol. 2009; 30: 494–501. ValdimarssonH ThorleifsdottirRH SigurdardottirSL GudjonssonJE JohnstonA Psoriasis - as an autoimmune disease caused by molecular mimicry Trends Immunol 2009 30 494 501 10.1016/j.it.2009.07.00819781993 Search in Google Scholar

[36] Yamamoto T, Katayama I, Nishioka K. Peripheral blood mononuclear cell proliferative response against staphylococcal superantigens in patients with psoriasis arthropathy. Eur J Dermatol. 1999; 9: 17–21. YamamotoT KatayamaI NishiokaK Peripheral blood mononuclear cell proliferative response against staphylococcal superantigens in patients with psoriasis arthropathy Eur J Dermatol 1999 9 17 21 Search in Google Scholar

[37] Ruiz-Romeu E, Ferran M, Sagristà M, Gómez J, Giménez-Arnau A, Herszenyi K, Hóllo P, Celada A, Pujol R, Santamaria-Babí LF. Streptococcus pyogenes–induced cutaneous lymphocyte antigen-positive T cell-dependent epidermal cell activation triggers TH17 responses in patients with guttate psoriasis. J Allergy Clin Immunol. 2016; 138: 491–499.e6. Ruiz-RomeuE FerranM SagristàM GómezJ Giménez-ArnauA HerszenyiK HólloP CeladaA PujolR Santamaria-BabíLF Streptococcus pyogenes–induced cutaneous lymphocyte antigen-positive T cell-dependent epidermal cell activation triggers TH17 responses in patients with guttate psoriasis J Allergy Clin Immunol 2016 138 491 499.e6 10.1016/j.jaci.2016.02.00827056267 Search in Google Scholar

[38] Ferran M, Galván AB, Rincón C, Romeu ER, Sacrista M, Barboza E, Giménez-Arnau A, Celada A, Pujol RM, Santamaria-Babí LF. Streptococcus induces circulating CLA+ memory T-cell-dependent epidermal cell activation in psoriasis. J Invest Dermatol. 2013; 133: 999–1007. FerranM GalvánAB RincónC RomeuER SacristaM BarbozaE Giménez-ArnauA CeladaA PujolRM Santamaria-BabíLF Streptococcus induces circulating CLA+ memory T-cell-dependent epidermal cell activation in psoriasis J Invest Dermatol 2013 133 999 1007 10.1038/jid.2012.41823190888 Search in Google Scholar

[39] Haapasalo K, Koskinen LL, Suvilehto J, Jousilahti P, Wolin A, Suomela S, Trembath R, Barker J, Vuopio J, Kere J, et al. The psoriasis risk allele HLA-C’06:02 shows evidence of association with chronic or recurrent streptococcal tonsillitis. Infect Immun. 2018; 86: e00304–18. HaapasaloK KoskinenLL SuvilehtoJ JousilahtiP WolinA SuomelaS TrembathR BarkerJ VuopioJ KereJ The psoriasis risk allele HLA-C’06:02 shows evidence of association with chronic or recurrent streptococcal tonsillitis Infect Immun 2018 86 e00304 18 10.1128/IAI.00304-18620472930037793 Search in Google Scholar

[40] Ståhle M, Atakan N, Boehncke WH, Chimenti S, Daudén E, Giannetti A, Hoeger P, Joly P, Katsambas A, Kragballe K, et al. Juvenile psoriasis and its clinical management: A European expert group consensus. J Dtsch Dermatol Ges. 2010; 8: 812–818. StåhleM AtakanN BoehnckeWH ChimentiS DaudénE GiannettiA HoegerP JolyP KatsambasA KragballeK Juvenile psoriasis and its clinical management: A European expert group consensus J Dtsch Dermatol Ges 2010 8 812 818 10.1111/j.1610-0387.2010.07507.x20738459 Search in Google Scholar

[41] Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: A prospective study. Br J Dermatol. 2003; 149: 530–534. GudjonssonJE ThorarinssonAM SigurgeirssonB KristinssonKG ValdimarssonH Streptococcal throat infections and exacerbation of chronic plaque psoriasis: A prospective study Br J Dermatol 2003 149 530 534 10.1046/j.1365-2133.2003.05552.x14510985 Search in Google Scholar

[42] Lesan S, Toosi R, Aliakbarzadeh R, Daneshpazhooh M, Mahmoudi L, Tavakolpour S, Mahmoudi H. Oral Candida colonization and plaque type psoriasis: Is there any relationship? J Investig Clin Dent. 2018; 9: e12335. LesanS ToosiR AliakbarzadehR DaneshpazhoohM MahmoudiL TavakolpourS MahmoudiH Oral Candida colonization and plaque type psoriasis: Is there any relationship? J Investig Clin Dent 2018 9 e12335 10.1111/jicd.1233529603683 Search in Google Scholar

[43] Vitkov L, Weitgasser R, Hannig M, Fuchs K, Krautgartner WD. Candida-induced stomatopyrosis and its relation to diabetes mellitus. J Oral Pathol Med. 2003; 32: 46–50. VitkovL WeitgasserR HannigM FuchsK KrautgartnerWD Candida-induced stomatopyrosis and its relation to diabetes mellitus J Oral Pathol Med 2003 32 46 50 10.1034/j.1600-0714.2003.00020.x12558958 Search in Google Scholar

[44] Monea A, Santacroce L, Marrelli M, Man A. Oral candidiasis and inflammatory response: A potential synergic contribution to the onset of type-2 diabetes mellitus. Australas Med J. 2017; 10: 550–556. MoneaA SantacroceL MarrelliM ManA Oral candidiasis and inflammatory response: A potential synergic contribution to the onset of type-2 diabetes mellitus Australas Med J 2017 10 550 556 Search in Google Scholar

[45] Owczarczyk-Saczonek A, Placek W. Compounds of psoriasis with obesity and overweight. Postepy Hig Med Dosw. 2017; 71: 761–772. Owczarczyk-SaczonekA PlacekW Compounds of psoriasis with obesity and overweight Postepy Hig Med Dosw 2017 71 761 772 10.5604/01.3001.0010.385428894050 Search in Google Scholar

[46] Brook I, Gober AE. Effect of smoking cessation on the microbial flora. Arch Otolaryngol Head Neck Surg. 2007; 133: 135–138. BrookI GoberAE Effect of smoking cessation on the microbial flora Arch Otolaryngol Head Neck Surg 2007 133 135 138 10.1001/archotol.133.2.13517309981 Search in Google Scholar

[47] Mokeem SA, Abduljabbar T, Al-Kheraif AA, Alasqah MN, Michelogiannakis D, Samaranayake LP, Javed F. Oral Candida carriage among cigarette- and waterpipe-smokers, and electronic cigarette users. Oral Candida carriage among cigarette- and waterpipe-smokers, and electronic cigarette users. Oral Dis. 2019; 25: 319–326. MokeemSA AbduljabbarT Al-KheraifAA AlasqahMN MichelogiannakisD SamaranayakeLP JavedF Oral Candida carriage among cigarette- and waterpipe-smokers, and electronic cigarette users. Oral Candida carriage among cigarette- and waterpipe-smokers, and electronic cigarette users Oral Dis 2019 25 319 326 10.1111/odi.1290229800492 Search in Google Scholar

[48] Pietrzak A, Grywalska E, Socha M, Roliński J, Franciszkiewicz-Pietrzak K, Rudnicka L, Rudzki M, Krasowska D. Prevalence and possible role of candida species in patients with psoriasis: A systematic review and meta-analysis. Mediators Inflamm. 2018; 2018: 9602362. PietrzakA GrywalskaE SochaM RolińskiJ Franciszkiewicz-PietrzakK RudnickaL RudzkiM KrasowskaD Prevalence and possible role of candida species in patients with psoriasis: A systematic review and meta-analysis Mediators Inflamm 2018 2018 9602362 10.1155/2018/9602362596051829853795 Search in Google Scholar

[49] Picciani BL, Michalski-Santos B, Carneiro S, Sampaio AL, Avelleira JC, Azulay DR, Pinto JM, Dias EP. Oral candidiasis in patients with psoriasis: Correlation of oral examination and cytopathological evaluation with psoriasis disease severity and treatment. J Am Acad Dermatol. 2013; 68: 986–991. PiccianiBL Michalski-SantosB CarneiroS SampaioAL AvelleiraJC AzulayDR PintoJM DiasEP Oral candidiasis in patients with psoriasis: Correlation of oral examination and cytopathological evaluation with psoriasis disease severity and treatment J Am Acad Dermatol 2013 68 986 991 10.1016/j.jaad.2012.11.03323384796 Search in Google Scholar

[50] Fadel HT, Flytström I, Calander AM, Bergbrant IM, Heijl L, Birkhed D. Profiles of dental caries and periodontal disease in individuals with or without psoriasis. J Periodontol. 2013; 84: 477–485. FadelHT FlytströmI CalanderAM BergbrantIM HeijlL BirkhedD Profiles of dental caries and periodontal disease in individuals with or without psoriasis J Periodontol 2013 84 477 485 10.1902/jop.2012.12011922631882 Search in Google Scholar

[51] Preus HR, Khanifam P, Kolltveit K, Mørk C, Gjermo P. Periodontitis in psoriasis patients: A blinded, case-controlled study. Acta Odontol Scand. 2010; 68: 165–170. PreusHR KhanifamP KolltveitK MørkC GjermoP Periodontitis in psoriasis patients: A blinded, case-controlled study Acta Odontol Scand 2010 68 165 170 10.3109/0001635090358367820141361 Search in Google Scholar

[52] Skudutyte-Rysstad R, Slevolden EM, Hansen BF, Sandvik L, Preus HR. Association between moderate to severe psoriasis and periodontitis in a Scandinavian population. BMC Oral Health. 2014; 14: 139. Skudutyte-RysstadR SlevoldenEM HansenBF SandvikL PreusHR Association between moderate to severe psoriasis and periodontitis in a Scandinavian population BMC Oral Health 2014 14 139 10.1186/1472-6831-14-139428068825427764 Search in Google Scholar

[53] Ungprasert P, Wijarnpreecha K, Wetter DA. Periodontitis and risk of psoriasis: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017; 31: 857–862. UngprasertP WijarnpreechaK WetterDA Periodontitis and risk of psoriasis: A systematic review and meta-analysis J Eur Acad Dermatol Venereol 2017 31 857 862 10.1111/jdv.14051540831227862342 Search in Google Scholar

[54] Antal M, Braunitzer G, Mattheos N, Gyulai R, Nagy K. Smoking as a permissive factor of periodontal disease in psoriasis. PLoS One. 2014; 9: e92333. AntalM BraunitzerG MattheosN GyulaiR NagyK Smoking as a permissive factor of periodontal disease in psoriasis PLoS One 2014 9 e92333 10.1371/journal.pone.0092333396131024651659 Search in Google Scholar

[55] Dalmády S, Kemény L, Antal M, Gyulai R. Periodontitis: A newly identified comorbidity in psoriasis and psoriatic arthritis. Expert Rev Clin Immunol. 2020; 16: 101–108. DalmádyS KeményL AntalM GyulaiR Periodontitis: A newly identified comorbidity in psoriasis and psoriatic arthritis Expert Rev Clin Immunol 2020 16 101 108 10.1080/1744666X.2019.170011331825680 Search in Google Scholar

[56] Egeberg A, Mallbris L, Gislason G, Hansen PR, Mrowietz U. Risk of periodontitis in patients with psoriasis and psoriatic arthritis. J Eur Acad Dermatol Venereol. 2017; 31: 288–293. EgebergA MallbrisL GislasonG HansenPR MrowietzU Risk of periodontitis in patients with psoriasis and psoriatic arthritis J Eur Acad Dermatol Venereol 2017 31 288 293 10.1111/jdv.1381427439545 Search in Google Scholar

[57] Ganzetti G, Campanati A, Santarelli A, Pozzi V, Molinelli E, Minnetti I, Brisigotti V, Procaccini M, Emanuelli M, Offidani A. Involvement of the oral cavity in psoriasis: Results of a clinical study. Br J Dermatol. 2015; 172: 282–285. GanzettiG CampanatiA SantarelliA PozziV MolinelliE MinnettiI BrisigottiV ProcacciniM EmanuelliM OffidaniA Involvement of the oral cavity in psoriasis: Results of a clinical study Br J Dermatol 2015 172 282 285 10.1111/bjd.1320125078556 Search in Google Scholar

[58] Cutler CW, Jotwani R. Dendritic cells at the oral mucosal interface. J Dent Res. 2006; 85: 678–689. CutlerCW JotwaniR Dendritic cells at the oral mucosal interface J Dent Res 2006 85 678 689 10.1177/154405910608500801225418516861283 Search in Google Scholar

[59] Nakib S, Han J, Li T, Joshipura K, Qureshi AA. Periodontal disease and risk of psoriasis among nurses in the United States. Acta Odontol Scand. 2013; 71: 1423–1429. NakibS HanJ LiT JoshipuraK QureshiAA Periodontal disease and risk of psoriasis among nurses in the United States Acta Odontol Scand 2013 71 1423 1429 10.3109/00016357.2013.766360421426523374087 Search in Google Scholar

[60] Moutsopoulos NM, Kling HM, Angelov N, Jin W, Palmer RJ, Nares S, Osorio M, Wahl SM. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun. 2012; 39: 294–303. MoutsopoulosNM KlingHM AngelovN JinW PalmerRJ NaresS OsorioM WahlSM Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis J Autoimmun 2012 39 294 303 10.1016/j.jaut.2012.03.003341694722560973 Search in Google Scholar

[61] Behrens F, Koehm M, Thaçi D, Gnann H, Greger G, Wittig BM, Burkhardt H. Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis. Rheumatology. 2016; 55: 1791–1795. BehrensF KoehmM ThaçiD GnannH GregerG WittigBM BurkhardtH Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis Rheumatology 2016 55 1791 1795 10.1093/rheumatology/kew229503421827330166 Search in Google Scholar

[62] Rosina P, Chieregato C, Miccolis D, D’Onghia FS. Psoriasis and side-effects of mesotherapy. Int J Dermatol. 2001; 40: 581–583. RosinaP ChieregatoC MiccolisD D’OnghiaFS Psoriasis and side-effects of mesotherapy Int J Dermatol 2001 40 581 583 10.1046/j.1365-4362.2001.01248-3.x11737454 Search in Google Scholar

[63] Peyerl FW, Varsos GV, Shen M, Lodaya K, Gannu L, Shenoy A, Hayashida DK, D’Souza F. Psy19 comorbidities, infections and treatment patterns in psoriasis patients: A retrospective analysis of a large US electronic health record database. Value Heal. 2019; 22: 378. PeyerlFW VarsosGV ShenM LodayaK GannuL ShenoyA HayashidaDK D’SouzaF Psy19 comorbidities, infections and treatment patterns in psoriasis patients: A retrospective analysis of a large US electronic health record database Value Heal 2019 22 378 10.1016/j.jval.2019.04.1844 Search in Google Scholar

[64] Muto M, Date Y, Ichimiya M, Moriwaki Y, Mori K, Kamikawaji N, Kimura A, Sasazuki T, Asagami C. Significance of antibodies to streptococcal M protein in psoriatic arthritis and their association with HLAA*0207. Tissue Antigens. 1996; 48: 645–650. MutoM DateY IchimiyaM MoriwakiY MoriK KamikawajiN KimuraA SasazukiT AsagamiC Significance of antibodies to streptococcal M protein in psoriatic arthritis and their association with HLAA*0207 Tissue Antigens 1996 48 645 650 10.1111/j.1399-0039.1996.tb02687.x9008306 Search in Google Scholar

[65] Wang Q, Vasey FB, Mahfood JP, Valeriano J, Kanik KS, Anderson BE, Bridgeford PH. V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum. 1999; 42: 2055–2059. WangQ VaseyFB MahfoodJP ValerianoJ KanikKS AndersonBE BridgefordPH V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis Arthritis Rheum 1999 42 2055 2059 10.1002/1529-0131(199910)42:10<2055::AID-ANR5>3.0.CO;2-A Search in Google Scholar

[66] Thumboo J, Uramoto K, Shbeeb MI, O’Fallon WM, Crowson CS, Gibson LE, Michet CJ Jr, Gabriel SE. Risk factors for the development of psoriatic arthritis: A population based nested case control study. J Rheumatol. 2002; 29: 757–762. ThumbooJ UramotoK ShbeebMI O’FallonWM CrowsonCS GibsonLE MichetCJJr GabrielSE Risk factors for the development of psoriatic arthritis: A population based nested case control study J Rheumatol 2002 29 757 762 Search in Google Scholar

[67] Rahman MU, Ahmed S, Schumacher HR, Zeiger AR. High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides. J Rheumatol. 1990; 17: 621–625. RahmanMU AhmedS SchumacherHR ZeigerAR High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides J Rheumatol 1990 17 621 625 Search in Google Scholar

[68] Lapadula G, Covelli M, Numo R. Antibacterial antibody pattern in seronegative spondyloarthropathies (SNSA). Clin Exp Rheumatol. 1988; 6: 385–390. LapadulaG CovelliM NumoR Antibacterial antibody pattern in seronegative spondyloarthropathies (SNSA) Clin Exp Rheumatol 1988 6 385 390 Search in Google Scholar

[69] Silveira LH, Gutiérrez F, Scopelitis E, Cuéllar ML, Citera G, Espinoza LR. Chlamydia-induced reactive arthritis. Rheum Dis Clin North Am. 1993; 19: 351–362. SilveiraLH GutiérrezF ScopelitisE CuéllarML CiteraG EspinozaLR Chlamydia-induced reactive arthritis Rheum Dis Clin North Am 1993 19 351 362 10.1016/S0889-857X(21)00191-5 Search in Google Scholar

[70] Louthrenoo W. Musculoskeletal manifestations of HIV infection in Thailand: An analysis of 100 cases. J Clin Rheumatol. 1997; 3: 258–268. LouthrenooW Musculoskeletal manifestations of HIV infection in Thailand: An analysis of 100 cases J Clin Rheumatol 1997 3 258 268 10.1097/00124743-199710000-00004 Search in Google Scholar

[71] Njobvu PD, McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol. 2000; 27: 1699–1702. NjobvuPD McGillP Psoriatic arthritis and human immunodeficiency virus infection in Zambia J Rheumatol 2000 27 1699 1702 Search in Google Scholar

[72] Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: Pathogenesis, clinical features, and management. Lancet Infect Dis. 2010; 10: 470–478. MorarN Willis-OwenSA MaurerT BunkerCB HIV-associated psoriasis: Pathogenesis, clinical features, and management Lancet Infect Dis 2010 10 470 478 10.1016/S1473-3099(10)70101-8 Search in Google Scholar

[73] Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, Taams LS, Kirkham BW. Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol. 2014; 66: 1272–1281. MenonB GullickNJ WalterGJ RajasekharM GarroodT EvansHG TaamsLS KirkhamBW Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression Arthritis Rheumatol 2014 66 1272 1281 10.1002/art.38376 Search in Google Scholar

[74] Mehraein Y, Lennerz C, Ehlhardt S, Venzke T, Ojak A, Remberger K, Zang KD. Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis. Mod Pathol. 2003; 16: 811–817. MehraeinY LennerzC EhlhardtS VenzkeT OjakA RembergerK ZangKD Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis Mod Pathol 2003 16 811 817 10.1097/01.MP.0000083145.68333.9B Search in Google Scholar

[75] Mehraein Y, Lennerz C, Ehlhardt S, Kemberger K, Ojak A, Zang KD. Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol, 2004; 17: 781–789. MehraeinY LennerzC EhlhardtS KembergerK OjakA ZangKD Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization Mod Pathol 2004 17 781 789 10.1038/modpathol.3800119 Search in Google Scholar

[76] Kozłowska D, Myśliwiec H, Flisiak I. Inflammation and lipid metabolism as a strong background connecting psoriasis and liver diseases. Przegl Dermatol. 2020; 107: 257–272. KozłowskaD MyśliwiecH FlisiakI Inflammation and lipid metabolism as a strong background connecting psoriasis and liver diseases Przegl Dermatol 2020 107 257 272 10.5114/dr.2020.97819 Search in Google Scholar

[77] Zhou L, Du GS, Pan LC, Zheng YG, Liu ZJ, Shi HD, Yang SZ, Shi XJ, Xuan M, Feng L.K, Zhu ZD. Sirolimus treatment for cirrhosis or hepatocellular carcinoma patients accompanied by psoriasis after liver transplantation: A single center experience. Oncol Lett. 2017; 14: 7817–7824. ZhouL DuGS PanLC ZhengYG LiuZJ ShiHD YangSZ ShiXJ XuanM FengL.K ZhuZD Sirolimus treatment for cirrhosis or hepatocellular carcinoma patients accompanied by psoriasis after liver transplantation: A single center experience Oncol Lett 2017 14 7817 7824 10.3892/ol.2017.7217575522329344227 Search in Google Scholar

[78] Piaserico S, Messina F. Russo FP. Managing psoriasis in patients with HBV or HCV infection: Practical considerations. Am J Clin Dermatol. 2019; 20: 829–845. PiasericoS MessinaF RussoFP Managing psoriasis in patients with HBV or HCV infection: Practical considerations Am J Clin Dermatol 2019 20 829 845 10.1007/s40257-019-00457-331222626 Search in Google Scholar

[79] Happle R, Kluger N. Koebner's sheep in Wolf's clothing: Does the isotopic response exist as a distinct phenomenon? J Eur Acad Dermatol Venereol. 2018; 32: 542–543. HappleR KlugerN Koebner's sheep in Wolf's clothing: Does the isotopic response exist as a distinct phenomenon? J Eur Acad Dermatol Venereol 2018 32 542 543 10.1111/jdv.1466429080318 Search in Google Scholar

[80] Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019; 20: 4347. KamiyaK KishimotoM SugaiJ KomineM OhtsukiM Risk factors for the development of psoriasis Int J Mol Sci 2019 20 4347 10.3390/ijms20184347676976231491865 Search in Google Scholar

[81] Weiss G, Shemer A, Trau H. The Koebner phenomenon: Review of the literature. J Eur Acad Dermatol Venereol. 2002; 16: 241–248. WeissG ShemerA TrauH The Koebner phenomenon: Review of the literature J Eur Acad Dermatol Venereol 2002 16 241 248 10.1046/j.1473-2165.2002.00406.x12195563 Search in Google Scholar

[82] Ji YZ, Liu SR. Koebner phenomenon leading to the formation of new psoriatic lesions: Evidences and mechanisms. Biosci Rep. 2019; 39: BSR20193266. JiYZ LiuSR Koebner phenomenon leading to the formation of new psoriatic lesions: Evidences and mechanisms Biosci Rep 2019 39 BSR20193266 10.1042/BSR20193266689316431710084 Search in Google Scholar

[83] Raychaudhuri SP, Jiang WY, Raychaudhuri SK. Revisiting the Koebner phenomenon: Role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol. 2008; 172: 961–971. RaychaudhuriSP JiangWY RaychaudhuriSK Revisiting the Koebner phenomenon: Role of NGF and its receptor system in the pathogenesis of psoriasis Am J Pathol 2008 172 961 971 10.2353/ajpath.2008.070710227642018349121 Search in Google Scholar

[84] Owczarczyk-Saczonek A, Krajewska-Włodarczyk M, Kasprowicz-Furmańczyk M, Placek W. Immunological memory of psoriatic lesions. Int J Mol Sci. 2020; 21: 62525. Owczarczyk-SaczonekA Krajewska-WłodarczykM Kasprowicz-FurmańczykM PlacekW Immunological memory of psoriatic lesions Int J Mol Sci 2020 21 62525 10.3390/ijms21020625701414831963581 Search in Google Scholar

[85] Grodner C, Beauchet A, Fougerousse AC, Quiles-Tsimaratos N, Perrot JL, Barthelemy H, Parier J, Maccari F, Beneton N, Bouilly-Auvray D, et al. Tattoo complications in treated and non-treated psoriatic patients. J Eur Acad Dermatol Venereol. 2020; 34: 888–896. GrodnerC BeauchetA FougerousseAC Quiles-TsimaratosN PerrotJL BarthelemyH ParierJ MaccariF BenetonN Bouilly-AuvrayD Tattoo complications in treated and non-treated psoriatic patients J Eur Acad Dermatol Venereol 2020 34 888 896 10.1111/jdv.1597531568596 Search in Google Scholar

[86] Tammaro A, Romano I, Parisella F, Persechino F, Persechino S. A case of Koebner phenomenon in a patient with tattoo to lips. J Cosmet Laser Ther. 2016; 22;1–7. TammaroA RomanoI ParisellaF PersechinoF PersechinoS A case of Koebner phenomenon in a patient with tattoo to lips J Cosmet Laser Ther 2016 22 1 7 10.1080/14764172.2016.119740127331422 Search in Google Scholar

[87] Kluger N. Tattooing and psoriasis: Demographics, motivations and attitudes, complications, and impact on body image in a series of 90 Finnish patients. Acta Dermatovenerol Alp Pannonica Adriat. 2017; 26: 29–32. KlugerN Tattooing and psoriasis: Demographics, motivations and attitudes, complications, and impact on body image in a series of 90 Finnish patients Acta Dermatovenerol Alp Pannonica Adriat 2017 26 29 32 10.15570/actaapa.2017.928632882 Search in Google Scholar

[88] Mataix J, Silvestre JF. Cutaneous adverse reactions to tattoos and piercings. Actas Dermosifiliogr. 2009; 100: 643–656. MataixJ SilvestreJF Cutaneous adverse reactions to tattoos and piercings Actas Dermosifiliogr 2009 100 643 656 10.1016/S1578-2190(09)70146-5 Search in Google Scholar

[89] Baş Y, Seçkin HY, Takcı Z. Psoriasis vulgarisli bir hastada alyansa ba-li demonstratif Köbner fenomeni. Turkderm Arch Turk Dermatol Venerology. 2016; 50: 166–167. BaşY SeçkinHY TakcıZ Psoriasis vulgarisli bir hastada alyansa ba-li demonstratif Köbner fenomeni Turkderm Arch Turk Dermatol Venerology 2016 50 166 167 Search in Google Scholar

[90] Streit E, Vogelgsang LE. ECG-induced koebner phenomenon. N Engl J Med. 2017; 377: 2180. StreitE VogelgsangLE ECG-induced koebner phenomenon N Engl J Med 2017 377 2180 10.1056/NEJMicm170699329171822 Search in Google Scholar

[91] Bronckers IM, Maatkamp M, Kievit W, van de Kerkhof PC, de Jong EM, Seyger MM. The association of scalp psoriasis with overall psoriasis severity and koebnerization in children: Cross-sectional findings from the Dutch Child-CAPTURE registry. Br J Dermatol. 2019; 181: 1099–1101. BronckersIM MaatkampM KievitW van de KerkhofPC de JongEM SeygerMM The association of scalp psoriasis with overall psoriasis severity and koebnerization in children: Cross-sectional findings from the Dutch Child-CAPTURE registry Br J Dermatol 2019 181 1099 1101 10.1111/bjd.1816831127952 Search in Google Scholar

[92] Omland SH, Gniadecki R. Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris? Clin Dermatol. 2015; 33: 456–461. OmlandSH GniadeckiR Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris? Clin Dermatol 2015 33 456 461 10.1016/j.clindermatol.2015.04.00726051061 Search in Google Scholar

[93] Zanchi M, Favot F, Bizzarini M, Piai M, Donini M, Sedona P. Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol. 2008; 22: 431–436. ZanchiM FavotF BizzariniM PiaiM DoniniM SedonaP Botulinum toxin type-A for the treatment of inverse psoriasis J Eur Acad Dermatol Venereol 2008 22 431 436 10.1111/j.1468-3083.2007.02457.x18363911 Search in Google Scholar

[94] Kolesnik M, Franke I, Lux A, Quist SR, Gollnick HP. Eczema in psoriatico: An important differential diagnosis between chronic allergic contact dermatitis and psoriasis in palmoplantar localization. Acta Derm Venereol. 2018; 98: 50–58. KolesnikM FrankeI LuxA QuistSR GollnickHP Eczema in psoriatico: An important differential diagnosis between chronic allergic contact dermatitis and psoriasis in palmoplantar localization Acta Derm Venereol 2018 98 50 58 10.2340/00015555-277928853491 Search in Google Scholar

[95] Skudlik C, Geier J, John SM. Current trends in occupational dermatology. Hautarzt. 2014; 65: 983–995. SkudlikC GeierJ JohnSM Current trends in occupational dermatology Hautarzt 2014 65 983 995 10.1007/s00105-014-3530-825359544 Search in Google Scholar

[96] Skudlik C, John SM. Psoriasis and Work. In: Kanerva's Occupational Dermatology, eds.: S John, J Johansen, T Rustemeyer, P Elsner, H Maibach. Springer, Cham 2020, 461–466. SkudlikC JohnSM Psoriasis and Work In: Kanerva's Occupational Dermatology eds.: JohnS JohansenJ RustemeyerT ElsnerP MaibachH Springer Cham 2020 461 466 10.1007/978-3-319-68617-2_32 Search in Google Scholar

[97] Cordan Yazıcı A, Ünlü B, İkizoğlu G. Complementary and alternative medicine use among patients with psoriasis on different treatment regimens. Arch Dermatol Res. 2020; 312: 601–604. Cordan YazıcıA ÜnlüB İkizoğluG Complementary and alternative medicine use among patients with psoriasis on different treatment regimens Arch Dermatol Res 2020 312 601 604 10.1007/s00403-019-02022-831820087 Search in Google Scholar